Eric Morgen

CIK: 0002036289

Transaction Breakdown

Open Market Buys (P)0 (0.0%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)7 (100.0%)

Compensation grants

Other (G, F, J, C, D, …)0 (0.0%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

BIOA

BioAge Labs, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (7 total)

BIOA
BioAge Labs, Inc.
Feb 17, 2026
Award(A)
Stock Option (Right to Buy)
Indirect
12.5K shares-
BIOA
BioAge Labs, Inc.
Feb 17, 2026
Award(A)
Stock Option (Right to Buy)
Direct
110K shares-
BIOA
BioAge Labs, Inc.
Feb 18, 2025
Award(A)
Stock Option (Right to Buy)
Indirect
25K shares-
BIOA
BioAge Labs, Inc.
Feb 18, 2025
Award(A)
Stock Option (Right to Buy)
Direct
200K shares-
BIOA
BioAge Labs, Inc.
Sep 25, 2024
Award(A)
Stock Option (Right to Buy)
Indirect
5K shares-
BIOA
BioAge Labs, Inc.
Apr 17, 2024
Award(A)
Stock Option (Right to Buy)
Indirect
13.6K shares-
BIOA
BioAge Labs, Inc.
Apr 17, 2024
Award(A)
Stock Option (Right to Buy)
Direct
258K shares-

		Type	Shares	Price		Ownership
Feb 17, 2026	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	12,500	-	-	Indirect
Feb 17, 2026	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	110,000	-	-	Direct
Feb 18, 2025	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	25,000	-	-	Indirect
Feb 18, 2025	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	200,000	-	-	Direct
Sep 25, 2024	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	4,952	-	-	Indirect
Apr 17, 2024	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	13,598	-	-	Indirect
Apr 17, 2024	BIOA BioAge Labs, Inc.	Award(A) Stock Option (Right to Buy)	257,973	-	-	Direct

1-7 of 7 transactions

About Morgen Eric

Morgen Eric (SEC CIK 0002036289) files insider reports with the SEC as Chief Operating Officer of BioAge Labs, Inc. (BIOA).

Signal8 holds 5 ownership filings by Morgen Eric (1 Form 3, 4 Form 4), filed between Sep 25, 2024 and Feb 19, 2026. Those filings report 7 transactions, from Apr 17, 2024 to Feb 17, 2026. Signal8's Form 4 history starts in Sep 2024.

The business address on Morgen Eric's filings is in EMERYVILLE, CA.

Recent filings by Morgen Eric

Feb 17, 2026: Grants or awards of BIOA derivative securities (2 lines, Form 4, code A).
Feb 18, 2025: Grants or awards of BIOA derivative securities (2 lines, Form 4, code A).
Sep 25, 2024: Grant or award of BIOA derivative securities (Form 4, code A).
Apr 17, 2024: Grants or awards of BIOA derivative securities (2 lines, Form 4, code A).

Other insiders filing for BioAge Labs, Inc. (BIOA)

Barton Shane, Principal Accounting Officer
Pande Vijay Satyanand, Director
Hemrajani Rekha, Director
HEALY JAMES, Director
ENRIGHT PATRICK G, Director
Davidson Michael H., Director

How to read Form 4 transaction codes